Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 925-929

  Carpelan Holmstrom M ^a   Haglund, C ^a   Lundin, J ^a   Alfthan, H ^a   Stenman, U H ^a   Roberts, P J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CA 242; Carcinoembryonic antigen; Colorectal cancer; Human chorionic gonadotrophin beta; Neoplasm; Prognosis; Specific tissue polypeptide antigen; Tissue polypeptide antigen; Tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER STAGING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029737059     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.458     Document Type: Article

References (26)

1. ALFTHAN H, HAGLUND C, ROBERTS P AND STENMAN UH. (1992). Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res., 52, 4628-4633.
2. BOGENSCHÜTZ O, BRÜMMENDORF T, STAAB HJ, ANDERER FA AND KIENINGER G. (1986). Prognostic value of preoperative serum CEA level compared to clinical staging IV. Histological grading and tumor type in colorectal and gastric cancer. J. Surg. Oncol., 32, 165-173.
3. BRÜMMENDORF T, ANDERER FA, STAAB HJ, HORNUNG A, STUMPF E AND KIENINGER G. (1985). Prognostic value of preoperative serum CEA level compared to clinical staging: III. An Approach to scoring of prognostic factors in colorectal cancer. J. Surg. Oncol., 28, 263-269.
4. CARPELAN-HOLMSTRÖM M, HAGLUND C, KUUSELA P, JÄRVINEN H AND ROBERTS PJ. (1995). Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br. J. Cancer, 71, 868-872.
5. DE MELLO J, STRUTHERS L, TURNER R, COOPER EH, GILES GR AND THE YORKSHIRE REGIONAL GASTROINTESTINAL CANCER RESEARCH GROUP (1983). Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br. J. Cancer, 48, 341-348.
6. DEANS GT, PARKS TG, ROWLANDS BJ AND SPENCE RAJ. (1992). Prognostic factors in colorectal cancer. Br. J. Surg., 79, 608-613.
7. DHAR P, MOORE T, ZAMCHECK N AND KUPCHIK HZ. (1972). Carcinoembryonic antigen (CEA) in colonic cancer. JAMA, 221, 31-35.
8. FILELLA X, MOLINA R, GRAU JJ, PIQUE M, GARCIA-VALDECASAS JC, ASTUDILLO E, BIETE A, BORDAS JM, NOVELL A, CAMPO E AND BALLESTA AM. (1992). Prognostic value of Ca 19.9 levels in colorectal cancer. Ann. Surg., 55-59.
9. GOSLIN R, STEELE G, MACINTYRE J, MAYER R, SUGARBAKER P, GLEGHORN K, WILSON R AND ZAMCHECK N. (1980). The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg., 192, 747-751.
10. HALL NR, STEPHENSON BM, PURVES DA AND COOPER EH. (1994). The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br. J. Cancer, 70, 549-553.
11. HOHENBERGER P, SCHLAG PM, GERNETH T AND HERFARTH C. (1994). Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann. Surg., 219, 135-143.
12. JASS JR, ATKIN WS, CUZICK J, BUSSEY HJR, MORSON BC, NORTHOVER JMA AND TODD IP. (1986). The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology, 10, 437-459.
13. KUUSELA P, HAGLUND C AND ROBERTS PJ. (1991). Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br. J. Cancer, 63, 636-640.
14. LINDMARK G, BERGSTRÖM R, PÄHLMAN L AND GLIMELIUS B. (1995). The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br. J. Cancer, 71, 1090-1094.
15. MARCILLAC I, TROALEN F, BIDART JM, GHILLANI P, RIBRAG V, ESCUDIER B, MALASSAGNE B, DROZ JP, LHOMME C, ROUGIER P, DUVILLARD P, PRADE M, LUGAGNE P-M, RICHARD F, POYNARD T, BOHUON C, WANDS J AND BELLET D. (1992). Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res., 52, 3901-3907.
16. MOERTEL CG, O'FALLON JR, GO VL, O'CONNELL MJ AND THYNNE GS. (1986). The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer, 58, 603-610.
17. NILSSON O, JOHANSSON C, GLIMELIUS B, PERSSON B, NORGAARD-PEDERSEN B, ANDRÉN-SANDBERG Å AND LINDHOLM L. (1992). Sensitivity and specificity of CA 242 in gastrointestinal cancer. A comparison with CEA, CA50 and CA19-9. Br. J. Cancer, 65, 215-221.
18. SLENTZ K, SENAGORE A, HIBBERT J, MAZIER WP AND TALBOTT TM. (1994). Can preoperative and postoperative CEA predict survival after colon cancer resection? Am. Surg., 60, 528-532.
19. STAHLE E, GLIMELIUS B, BERGSTRÖM R AND PÅHLMAN L (1988a). Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage. Eur. J. Surg. Oncol., 14, 277-286.
20. STÅHLE E, GLIMELIUS B, BERGSTRÖM R AND PÅHLMAN L. (1988b). Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis. Eur. J. Surg. Oncol, 14, 287-296.
21. STEELE G, ELLENBERG S, RAMMING K, O'CONELL M, MOERTEL C, LESSNER H, BRUCKNER H, HORTON J, SCHEIN P, ZAMCHECK N, NOVAK J AND HOLYOKE ED. (1982). CEA monitoring among patients in multi-institutional adjuvant GI therapy protocols. Ann. Surg., 196, 162-169.
22. TURNBALL RB, KYLE K, WATSON FR AND SPRATT J. (1967). Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann. Surg., 166, 420-427.
23. WANEBO HJ, RAO B, PINSKY CM, HUFFMAN RG, STEARNS M, SCHWARTZ MK AND OETTGEN HF. (1978). Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N. Engl. J. Med., 299, 448-451.
24. WANG JY, TANG R AND CHIANG JM. (1994). Value of carcinoembryonic antigen in the management of colorectal cancer. Dis. Colon Rectum, 37, 272-277.
25. WIGGERS T, ARENDS JW AND VOLOVICS A. (1988). Regression analysis in prognostic factors in colorectal cancer after curative resections. Dis. Colon Rectum, 31, 33-41.
26. WOLMARK N, FISHER B, WIEAND HS AND HENRY RS. (1984). The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Ann. Surg., 199, 375-382.